[{"orgOrder":0,"company":"Aboca","sponsor":"Aboca","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"CANADA","productType":"Plant Extract\/Herbal","year":"2014","type":"Inapplicable","leadProduct":"Artichoke Extract","moa":"Undisclosed","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase II","graph3":"Aboca","amount2":0,"highestDevelopmentShortName":"Ph II","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Capsule","sponsorNew":"Aboca \/ Aboca","highestDevelopmentStatusID":"8","companyTruncated":"Aboca \/ Aboca"},{"orgOrder":0,"company":"Aboca","sponsor":"Latis","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"ITALY","productType":"Dietary Supplement","year":"2018","type":"Inapplicable","leadProduct":"Memormax","moa":"Undisclosed","graph1":"Neurology","graph2":"Undisclosed","graph3":"Aboca","amount2":0,"highestDevelopmentShortName":"Undisclosed","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Aboca \/ Latis","highestDevelopmentStatusID":"1","companyTruncated":"Aboca \/ Latis"},{"orgOrder":0,"company":"Aboca","sponsor":"Doppel Pharma | University of Roma La Sapienza | BMR Genomics","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"ITALY","productType":"Undisclosed","year":"2017","type":"Inapplicable","leadProduct":"Neobianacid","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase IV","graph3":"Aboca","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Undisclosed","sponsorNew":"Aboca \/ Doppel Pharma | University of Roma La Sapienza | BMR Genomics","highestDevelopmentStatusID":"11","companyTruncated":"Aboca \/ Doppel Pharma | University of Roma La Sapienza | BMR Genomics"},{"orgOrder":0,"company":"Aboca","sponsor":"Euromed Pharma Services | Ceinge | Latis | PhAST Consulting","pharmaFlowCategory":"DU","therapeuticArea":"Gastroenterology","country":"ITALY","productType":"Undisclosed","year":"2016","type":"Inapplicable","leadProduct":"Promelaxin","moa":"Undisclosed","graph1":"Gastroenterology","graph2":"Phase IV","graph3":"Aboca","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Gastroenterology","amount2New":0,"dosageForm":"Enema","sponsorNew":"Aboca \/ Euromed Pharma Services | Ceinge | Latis | PhAST Consulting","highestDevelopmentStatusID":"11","companyTruncated":"Aboca \/ Euromed Pharma Services | Ceinge | Latis | PhAST Consulting"},{"orgOrder":0,"company":"Aboca","sponsor":"Clalit","pharmaFlowCategory":"DU","therapeuticArea":"Pulmonary\/Respiratory Diseases","country":"ISRAEL","productType":"Undisclosed","year":"2013","type":"Inapplicable","leadProduct":"Undisclosed","moa":"Undisclosed","graph1":"Pulmonary\/Respiratory Diseases","graph2":"Phase IV","graph3":"Aboca","amount2":0,"highestDevelopmentShortName":"Ph IV","therapeuticAreaShortName":"Respiratory Diseases","amount2New":0,"dosageForm":"Syrup","sponsorNew":"Aboca \/ Aboca","highestDevelopmentStatusID":"11","companyTruncated":"Aboca \/ Aboca"}]